The Difficult to Express Protein Market is entering a period of technological development as manufacturers seek better ways to produce proteins with complex biological characteristics. According to WiseGuyReports, the market reached USD 15.1 billion in 2025 and is projected to reach USD 25 billion by 2035, growing at a CAGR of 5.1%.

A key market trend is the adoption of advanced expression technologies. CRISPR, synthetic biology, and improved microbial systems are helping researchers investigate ways to increase production efficiency and overcome protein-folding difficulties. These technologies may reduce production costs and make previously challenging proteins more commercially viable.

Sustainability is becoming equally important. Plant-based and microbial-based protein sources are attracting interest because they can support alternative approaches to conventional protein production. The report estimates that plant-based proteins will grow from USD 6 billion in 2024 to USD 10 billion by 2035, reflecting continuing demand for sustainable and health-oriented protein options.

The market's diverse application base provides additional resilience. Protein products can serve nutritional supplements, food and beverages, pharmaceuticals, and cosmetics. In pharmaceuticals, demand is closely connected with advanced therapeutics and personalized medicine, while food and nutrition applications benefit from changing consumer preferences and interest in specialized protein products.

Industry partnerships are also supporting innovation. WiseGuyReports identifies developments involving DSM and Nestlé, Ingredion and DuPont, and Cargill and a global food producer, illustrating the role of collaboration in advancing protein ingredients and fermentation-derived products.

North America is expected to remain the leading regional market, with Europe following as another important biotechnology center. Asia-Pacific is positioned for notable growth because of increasing investment in healthcare and biotechnology and rising demand for alternative protein solutions.

As the industry progresses, companies that combine advanced expression systems, scalable manufacturing, and sustainable production practices may be best positioned to capture emerging opportunities. The continued evolution of biotechnology should keep difficult-to-express proteins an important focus for research and commercial innovation.